...
首页> 外文期刊>European Journal of Obstetrics, Gynecology and Reproductive Biology: An International Journal >Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women.
【24h】

Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women.

机译:口服乳酸菌改善绝经后妇女阴道菌群的随机,双盲,安慰剂对照研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: The purpose of this randomized, double-blind, placebo-controlled study was to evaluate the influence of the orally administered probiotic strains Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the quality of the vaginal flora in postmenopausal women. STUDY DESIGN: Postmenopausal women with Nugent scores between 4 and 6 in initial vaginal swab, were randomized into two groups. Women in the intervention group received probiotic capsules containing 2.5x10(9)CFU (colony forming units) each of lyophilized L. rhamnosus GR-1 and L. reuteri RC-14 and women in the control group received an oral placebo once daily, in both groups for 14 days. Final vaginal swabs were taken 1 day after the last administration of the medication. The primary efficacy variable was a change in the Nugent score between baseline and the end of the study of at least two grades in each individual patient. RESULTS: Seventy two women were recruited in the study, 35 assigned to the intervention group and 37 to the control group. Twenty-one of the 35 subjects (60%) in the intervention group and 6 of the 37 subjects (16%) in the control group showed a reduction in the Nugent score by at least two grades. The difference in the number of patients with improvement was highly significant (p=0.0001). The median difference in Nugent scores between baseline and the end of the study was 3 in the intervention group and 0 in the control group (p=0.0001). CONCLUSION: Our results provide evidence for an alternative modality to restore the normal vaginal flora using specific probiotic strains administered orally.
机译:目的:这项随机,双盲,安慰剂对照研究旨在评估口服益生菌鼠李糖乳杆菌GR-1和罗伊氏乳杆菌RC-14对绝经后妇女阴道菌群质量的影响。研究设计:绝经后女性在最初的阴道拭子中Nugent得分在4到6之间的女性被随机分为两组。干预组中的妇女接受了益生菌胶囊,其中分别含有冻干的鼠李糖乳杆菌GR-1和罗伊氏乳杆菌RC-14的2.5x10(9)CFU(菌落形成单位),对照组的妇女每天口服一次安慰剂。两组共14天。最后一次阴道拭子在最后一次给药后1天服用。主要功效变量是每位患者中基线和研究结束之间至少两个等级的Nugent评分变化。结果:该研究招募了72名妇女,其中35名被分配到干预组,37名被分配到对照组。干预组的35名受试者中有21名(60%),对照组的37名受试者中有6名(16%)的Nugent得分降低了至少两个等级。改善患者的数量差异非常显着(p = 0.0001)。基线与研究结束之间,Nugent得分的中位数差异在干预组为3,在对照组为0(p = 0.0001)。结论:我们的结果提供了使用口服特定益生菌菌株恢复正常阴道菌群的替代方法的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号